NEW YORK (360Dx) – Analyte Health said Thursday it has reached a deal to provide certain patients access to IQuity's diagnostic tests.

Qualified patients will have immediate access to IsolateMS ­– IQuity's test to help clinicians decide whether a patient may have multiple sclerosis – through Analyte's Health Test Express website. The test is based on an RNA analytic process dubbed IQIsolate to confirm suspected autoimmune diagnosis.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

The Wall Street Journal looks into the cost of new gene therapies.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.